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Amelia Fiske, Barbara Prainsack, Alena Buyx 
 
 
Abstract: 
In its expansion to genomic, epidemiological and biomedical research, citizen science has 
been promoted as contributing to the democratization of medical research and health care. At 
the same time, it has been criticized for reinforcing patterns of exclusion in health and 
biomedicine, and sometimes even creating new ones. Although citizen science has the 
potential to make biomedical research more inclusive, the benefits of current citizen science 
initiatives are not equally accessible for all people – in particular those who are resource-poor, 
located outside of traditional networks of healthcare services, or members of minorities and 
marginalized groups. In view of growing public investments in participatory research 
endeavors, we argue that it should be considered more explicitly if, and how, citizen science 
could help make research more inclusive, contribute to the public good, and possibly even 
lead to better and more equitable healthcare. Reflecting on emerging ethical concerns for 
scientific conduct and best medical practice, we propose a set of systematic considerations for 
researchers, practitioners, bioethicists, funders, and participants who seek to advance ethical 
practices of citizen-led health initiatives, and address profound differences in position, 
privilege, and power in research. 
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 While the phenomenon of non-professional experts contributing to scientific 
knowledge creation is by no means a novelty of recent decades, the rapid advancement of 
digital technologies has fueled the expansion of “citizen science” into wider areas of 
medicine, genomics, epidemiology and public health.[1] The expansion of citizen science, 
also called citizen- or participant-led research, into areas of medical research has been framed 
as an important contribution to the democratization of research[2] adding new perspectives 
and value to clinical research,[3] and to health care more broadly.[4] Citizen science has born 
hopes of developing treatments for rare diseases, advancing public health directives, and 
extending recruitment in biomedical research,[5, 6] making it an increasingly central 
component of medical and health research and practice. The use of citizen science in 
medicine is also seen to bear the potential to make research more democratic and inclusive, 
for example by transforming hierarchies of expert and lay participation in knowledge 
production. 
At the same time, the expansion of citizen-led practices in health and medicine raises 
ethical concerns. For example, it may confound and replicate existing power structures, 
exclusions, and disparities in access to health resources, knowledge, and technologies. Some 
have called for a new social contract to govern the production of health knowledge in novel 
configurations,[7] while others have argued for more symmetrical engagements between 
biomedical ethicists, scientists, and publics.[8] In view of growing public investments in 
citizen-led endeavors, we argue that in addition to such approaches, we need to consider more 
explicitly whether, and how, citizen science could help make research more inclusive, 
foreground the aim of contributing to the public good, and possibly even lead to better and 
more equitable healthcare. Building on a background of established principles for ethical 
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scientific conduct, best research practices, and medical ethics,[9–11] our prior work on ethics, 
participation, motivation, and responsibility in citizen science,[1, 6, 12–16] and responding to 
scholarship on emerging issues of diversity and inclusion in biomedical research and 
practice,[17, 7, 18, 19, 2, 20] we propose a set of interdisciplinary considerations for 
researchers, practitioners, biomedical ethicists, funders, and participants alike in order to 
advance ethical practices of citizen-led health initiatives, and address profound differences in 
position, privilege, and power in research. 
 
New promises and new concerns 
 Citizen science – understood broadly as the participation of non-professionals at any 
phase of scientific research – has been celebrated for generating creative synergies of lay and 
expert collaboration to address health concerns.[9, 10] It is now easier than ever before for 
many lay individuals to participate in biomedical research. Popular news accounts describe 
patient-led research and how ‘Citizen science effort is empowering communities to advance 
health equity.’[23] Many initiatives embrace the rhetoric of participation and democratization, 
framing their work as ‘Personal health data for the public good’ (Health Data Exploration 
Project), or encouraging individuals to ‘Become a research partner. You can help make a 
difference,’ (mPower), speaking to debates over whether an ethical duty to participate in 
health data research exists.[24] The collection and sharing of personal data is promoted in 
many citizen-led projects as a means to facilitate advances in health for a broader community. 
Common types of citizen science range from gamified analytic tasks (e.g., Eyewire, FoldIt) to 
web-based self-recruiting in data intensive projects (e.g., Open Humans, PatientsLikeMe, 
Smart Patients). Other projects are dedicated to advancing research on rare conditions (e.g., 
MyDaughtersDNA, DIYGenomics), compiling biorepositories (e.g., American Gut Project, 
Healthbank), or recruiting citizens as data sensors (e.g., Flu near you, Mosquito Alert). In 
many cases, not only knowledge creation in the strict sense of the word, but also research and 
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project funding, are crowdsourced (e.g., YouCaring, SciFund)[13]. 
Yet, not everyone has been so enthusiastic. Critiques include that ‘participation’ is 
limited to specific tasks, rarely involves the formulation of hypotheses or theory, or only 
refers to the use of lay individuals’ biological material.[25] Initiatives tend to be utilized by a 
relatively select group of people, in particular those who are highly educated and already 
working in science or outreach spheres.[14, 15] Many projects suffer from demographic 
biases similar to ‘traditional’ medical research[16, 17] or speak only ‘about’ rather than ‘with’ 
vulnerable groups.[29] Those who previously were referred to as ‘research subjects’ are now 
‘participants’ and ‘proactive managers’ of their own health,[5] and research – understood this 
way – might be subject to less rigorous oversight intended to protect the rights of patient-
subjects.[30] In sum, there is growing concern that some participatory initiatives in health and 
medicine do not always fulfill the promises of citizen science regarding more democratic and 
inclusive research practices.  
While digital technologies and engagement possibilities through smartphones, 
wearables, handheld devices, and other tools are rapidly changing research practices, ethical 
frameworks to navigate the challenges of participatory practices have not been sufficiently 
developed, particularly in medicine. Some citizen projects are initiated and run by lay 
individuals, while others are started by research groups, non-profits, and companies and then 
invite publics to contribute. In this article, we use the term citizen as an umbrella term that 
captures a broad class of practices that encompass many different types of research, each with 
its own objectives, stakeholders, and ethical challenges. We do not attempt to classify the 
citizen science projects discussed here on the basis of their inputs, ‘bottom-up’ and ‘top-
down’ approaches, or stated goals because many of these are often blurred in practice (for 
further work on this and a typology of citizen science initiatives please see: [15]). Indeed, one 
challenge that has accompanied citizen science as a growing field of participatory practices in 
health research is its high level of heterogeneity; while underscoring the range of practices at 
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hand, we find that it is still productive to speak of a ‘field’ – albeit a broad and dynamic one – 
of citizen science of medicine in order to address key ethical and political concerns with this 
growing area of research.[1] We believe that ethical aspects should always be explored and 
addressed within the specific context of the project, its stated goals, participants, and relevant 
history.  
To aide such explorations, we propose a set of concerns that specifically address how 
citizen science of medicine, epidemiology, genomics, and public health meets, or does not 
meet, the needs of underserved populations. Given the diversity of practice subsumed under 
the umbrella term of citizen science, we develop recommendations to guide further practice 
and explore ethical concerns raised in citizen science of health (Table 1). We do this by 
building upon established frameworks of research and medical ethics [9–11], and by 
reflecting on debates in research and medical ethics, personalized medicine, and critical 
public health. We focus on consistent concerns specific to citizen-led initiatives, such as 
diversity, inclusion, and representation, that have not yet been fully addressed by traditional 
research ethics frameworks nor by citizen science efforts, and on the implications of current 
practices ranging from initiatives in public health, to crowdsourcing, to patient-led research in 
order to address a broad and ever-growing field of citizen science. In line with calls to address 
social problems such as inequity, racism, and bias in biomedical ethics,[31] we argue that 
researchers, practitioners, bioethicists, funders, and participants in citizen science initiatives 
should work to promote more inclusive, open, and equitable forms of engagement with health 
research. 
 
Conditions, Barriers, and Burdens of Participation  
 Even in more traditional forms of research, to be considered ethical, potential 
participants and communities should be involved early on in a ‘meaningful participatory 
process’.[9 Guideline 7] Citizen science provides a particularly striking opportunity to rethink 
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questions of fairness in knowledge production. The stated aspirations and advantages of many 
citizen science initiatives are of ‘open,’ ‘accessible,’ and ‘citizen-driven’ participation. Yet 
claims that citizen science will lead to ‘better’ outcomes compared to ‘traditional’ forms of 
scientific knowledge creation require empirical investigation.[32] Participatory processes are 
fraught with power imbalances between researchers and participants,[33] in particular when 
working across socio-economic gradients to ensure benefit to participating communities[34] 
or with marginalized groups.[35,36] In particular, medical research projects that uncritically 
promote public or patient ‘engagement’ have failed to create reciprocal and mutually-
beneficial relationships.[37] As was shown in community inclusion efforts in South Africa, 
for example, the mode of approach can be as important as the content of the intervention.[38] 
Thus, in line with guidance on ethical research in potentially vulnerable communities,[9, 
Guideline 7] the specific meaning of terms like ‘community’ or ‘public engagement’ within 
the context of a given project should be made explicit in the stated goals and invitations to 
participate. 
Further, knowledge production is always embedded in specific social, political, and 
institutional contexts. But arguably, types of knowledge production that prominently draw 
upon the work and ingenuity of non-professional experts represent a particular opportunity – 
and perhaps also responsibility – to foreground questions of equity and justice. As scholarship 
within feminist science studies has shown, questions of equity and justice are built into the 
design of things as fundamental as lab meetings, including how speaking time is allocated and 
how decisions are reached.[39] Scholarship addressing inequalities in specific political 
contexts has developed recommendations for research with historically marginalized groups, 
including the imperative of studying with members of Indigenous groups as full research 
partners who develop questions, own data, and get paid for labor.[40] Such guidelines build 
on a growing body of work in indigenous research methodologies,[41] and efforts to 
recognize concepts of reciprocity or place in empirical research.[42] Drawing from this, 
This is not the final version of the paper 
 
 7 
critical reflection on participation begins with an analysis of power differentials: How does a 
project proactively address disparities in position, access, experience, or resources?  What 
explicit codes of conduct do participants agree upon, and how are they determined? Attention 
needs to be paid not only to lay participant engagement, but also reciprocally to the quality 
and depth of the involvement of researchers themselves – reflecting particular obligations 
raised for those designing, running, and funding citizen science initiatives.[37] 
 Much of the expansion of citizen science has been facilitated by digital technologies, 
in particular smartphones, wearables, and the Internet. Yet, the accessibility of health data and 
digital technologies hinges closely on persistent socio-economic inequalities.[29, 30] Access 
must be considered multi-dimensionally, in terms of geography, language, skills, time, and 
tools: How do different groups engage with the technologies being used in the project? Are 
participants merely ‘consuming’ web content, or are they also able to alter or provide content? 
Do website descriptions include visual aids and multimedia pieces that explain in plain 
language the aims of the project, and how to participate? What forms of literacy (scientific, 
medical, digital, English language) are required? Iterative reflection on how these 
technologies and their modes of access (e.g. websites, apps, smartphones, wearable devices) 
might exclude certain groups, and how this could affect the evidence that is produced, 
becomes critical to any project aiming to improve access to health resources, in particular for 
disadvantaged participants. 
 Monetary aspects deserve special consideration as a barrier to participation. Unlike in 
more traditional forms of research, where participants should be reasonably reimbursed for 
their costs and compensated for their inconvenience and time,[9, Guideline 13] many citizen 
science initiatives rely on financial contributions from participants. Such contributions can be 
solicited either directly as a service or membership fee, or indirectly through the obligation to 
possess software or tools and could form obvious passage points that exclude certain groups. 
This practice shapes the resulting dataset: only people who can afford to do so have their guts 
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sampled and analyzed, for example. Projects that use a consumer-as-participant model have 
been found to employ a more limited kind of participation,[45] and financial conditions can 
compound other barriers such as computer access or time availability, raising the concern that 
citizen science might remain an upper class and largely white phenomenon.[46] The questions 
of why fee-for-participation models are accepted within some projects, and when it would be 
considered both unusual and problematic in traditional research,[9 Guideline 13] deserve 
more systematic probing and public debate.  
 The shift towards wider participation in science not only creates benefits, but it can 
affect the distribution of direct and indirect burdens and responsibilities borne by participants. 
In the area of medicine, public participation is changing what it means to be an informed and 
active patient. One of the most powerful cultural shifts that has accompanied participant-
driven genetic research has been growing social expectations that individuals should monitor 
and manage their own health.[8, 33] Particularly where the prevention and management of 
disease is framed as primarily an individual responsibility and not a collective duty, the 
possibility exists that citizen science could become a smokescreen for the retreat of public 
service-provision. Likewise, the celebration of participation could lead to the stigmatization 
of non-participation, disadvantaging those who do not participate in self-tracking, data 
sharing, or community research. We share the worry of Juengst et al[47] that in times of 
increasing budgetary pressures, healthcare systems could set priorities in favor of the 
‘empowered patient.’ It is thus imperative that participatory projects remain completely 
voluntary and not come to replace other, publically funded means of accessing treatment and 
care.  
 
Public Goods? Benefits and Distribution of Results  
 Many citizen science initiatives appeal broadly to the advancement of science, 
medicine, and the public good. Websites encourage individuals to contribute for the good of 
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‘the network’[26] or to address global problems. Vague encouragements to ‘Explore your gut 
and help science’ (UBiome) or calls to ‘donate your data, for you, for others, for good,’ 
(PatientsLikeMe), contemplate benefit in generic terms. What are the ethical implications of 
calling on pro-social motivations to entice participation without specifying the intended 
collective benefits[48] and how will they be delivered? As a condition of research ethics 
review in more traditional forms of research, the scientific and social value of the intended 
research initiative must be specified; these values can never override the rights of research 
subjects.[9 Guideline 1] Further, any research initiative must have an equitable distribution of 
benefits and burdens for participants.[9  Guidelines 3 and 4, 10] If citizen science initiatives 
are to avoid exacerbating inequalities in biomedical research, the benefits and harms of such 
projects need to be specified in greater detail. Delimitation of specific benefit would include 
anticipating who could be empowered and disempowered in the process. As practitioners 
working in public health have shown, concrete steps such as community advisory groups can 
help hold researchers accountable.[33] 
 Many citizen science projects seek to develop a new tool, product, or database for 
scientific use, which often includes the solicitation of contributions (time, biosamples, 
personal information, or knowledge) from lay actors. For project leaders and researchers 
seeking to promote equitable access of pro-social products, tools, and information, the 
following questions will be relevant: How can we make our products of better service, in 
particular those who need it the most? Several initiatives in the vein of ‘DIY’ science make 
public dissemination their explicit goal. In this spirit, projects in medicine, genetics, and 
public health could consider how their tools, databases, techniques, and therapies can be made 
widely available.  
 Finally, advances in digital media, portable devices, open-source databases, and social 
networking have broadened both the scope and speed by which publics can access and 
mobilize their own medical data and contribute to scientific knowledge production.[49] A 
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common assumption in the discourse on citizen science is that access to one’s own 
information leads to the democratization of research and healthcare.[4] Claims of 
democratization generally envision a world in which patients have full access to their own 
data as well as medical technologies and are thus able to take on a far more pro-active role in 
managing their health and wellbeing.[4,50] While it is doubtlessly true that data may 
empower some, claims of democratization merely via providing technical access to data have 
not been sufficiently demonstrated.[16] Data access policies mirror socioeconomic 
inequalities within an assumed egalitarian landscape.[51] Retaining a copy of individual-level 
data does not necessarily make the respective initiatives or society more democratic – 
although it can be an important step in this process. If, and how, access to uninterpreted data 
in citizen science can address matters of injustice and representation remains open for further 
consideration.  
 
Representation and Recognition 
 The ‘opening’ of the research process in citizen science raises new questions over 
representation, and has not been systematically addressed by established frameworks of 
research ethics within the context of health, biomedicine, and participant-led practices. The 
selection of an appropriately representative research population has been a central, albeit 
significantly contested, research aim for scientific studies.[52] Beyond scientific concerns, 
there are compelling ethical and political concerns surrounding the composition of a sample 
population. Non-representative study cohorts make it harder for some groups – such as 
women, people of color, the elderly – to get good medical care.[53] Particularly notorious in 
genomics,[54] genome-wide association studies underrepresent African, Latin American, 
indigenous populations.[17] This can result in personalized medicine being a tool of the 
few.[47] At the same time, markers of racial difference often conflate socially-constructed 
racial classifications with genetic diversity, thereby re-inscribing race in medicine and science 
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in troubling ways.[55] While the problem of representation is common to biomedical 
research, we focus on genetic and personalized medicine in order to address issues specific to 
recruitment and representation in citizen science.  
 Citizen science initiatives that are invested in the scientific search for diversity, such 
as in human gut flora or DNA, raise specific concerns.[56] One strain of citizen science aims 
to build large, public data sets (American and British Gut Projects). Others, like the 
Genographic Project seek to catalog the DNA of ‘unique’ populations, in order to ‘invite, 
encourage, and educate the public through participation in this real-time citizen-
science project’ (National Geographic). The solicitation and use of indigenous genetic 
samples is inherently problematic given histories of colonialism, fetishization of indigenous 
bloodlines, and potential for profit.[58] Challenging ‘collaborative’ projects like Genographic, 
Tallbear argues that the interests served are not the ‘traditional’ groups they sample from. 
Efforts to be genetically inclusive need to attend to long histories of colonial violence that 
inform the mapping of indigenous genomes. One immediate result that flows from this is that 
citizen science projects of this nature need to be co-directed by the groups being studied.[59] 
 Given that a swath of initiatives are dedicated to building public data sets, often 
including genetic analyses or advancing knowledge of rare diseases, the problem of 
representation is in need of explicit and continuous attention in order to ensure that 
assumptions about race are not re-inscribed in science, that the involvement of indigenous 
peoples in research is only as co-directors, and at the same time, that underserved groups are 
adequately considered in the search for medical interventions.[60] Which groups are 
represented in a project is an important question that needs to be discussed by and with 
(potential) participants, remaining open to revision throughout the project. 
 It is important to recognize the strong historical roots of citizen science within 
community-based and participatory health research, often in response to persistent health 
disparities and legacies of medical racism. Long before such efforts were called ‘citizen 
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science,’ marginalized groups took health research into their own hands, employing 
alternative modes of empirical inquiry, contesting authority, and pursuing public 
collaborations.[49, 50] A branch of emancipatory citizen science initiatives follows in this 
vein (e.g., Ciencia Forense Ciudadana). Yet, if citizen science of health is to strike a course 
divergent from traditional biomedical research, initiatives need to reckon with histories of 
racial and colonial violence that are entangled in the institutions of science, medicine, and the 
state. It remains a pertinent question if, and how, contemporary citizen science can offer a 
means of addressing historical marginalization. 
 
Trust, Risk, and Global Inequalities 
 Trust is an important factor in all forms of medical research.[9 Guideline 7] However, 
it is arguably of even higher importance in contemporary citizen science; many people would 
not participate in a project or initiative without trust in the organization or institution running 
it, as well as trust in fellow participants. Trust has been a perennial problem for biomedicine, 
as discussed for example in biobanking, organ donation, participation in clinical trials, and 
elsewhere.[51, 52] By involving lay people as ‘collaborators,’ citizen science has been 
proposed as a tool to bolster waning enrollments in biomedical studies,[6] to increase research 
population diversity, and to galvanize lay participation.[65] The involvement of members of 
marginalized groups in the development of research aims and recruitment strategies could 
open possibilities for addressing issues of exclusion in medicine. However, while there are 
compelling arguments to be made for the benefits of inclusive participation in research on the 
whole, and for promoting trust and transparency, discussion of different groups’ varying 
involvement in citizen science (whether distinguished by race class, gender, geographic 
location, education, etc.) needs to be probed not just as an issue of differing degrees of 
‘interest,’ but as situated within pertinent histories of marginalization.[66] 
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 Questions of trust are especially relevant in citizen science because, unlike 
conventional medical research, some citizen science initiatives – if they are led by patients, 
for example, and take place outside of established research institutions – do not undergo 
established risk-benefit analysis by internal review boards or research ethics committees.[30] 
While this can enable fast, non-bureaucratic research on issues of social import, it also brings 
problems. The risks of citizen science initiatives are often uncertain because many projects 
chart new territory in real-time reporting of disease, genomic research, or experimental 
therapies. The range of ethical concerns might widen along with new collaborative 
opportunities, particularly across borders. We can imagine situations where the collection and 
analysis of samples, reporting of real-time events, or sharing of personal data could pose 
personal harms to individuals while at the same time offering important insights of public 
health benefit. One example would be a farmer who risks losing her flock when reporting 
signs of avian flu.[67] 
 Potential harms that might be inherent to research are amplified along socioeconomic 
gradients and are especially relevant for marginalized, resource-poor populations. The 
inclusion of lay researcher populations from less-developed regions make this an important 
concern for citizen science initiatives, particularly those not mandated to undergo ethics 
review. The development of strategies to avoid or mitigate harm with an eye to global 
inequalities, as well as wider access to research ethics consultations in participatory health 
practices would be a strong step forward.[3] 
 
 
 
 
 
Table 1: Questions to ask for those designing, running, and funding citizen science 
initiatives 
 
 Concern Questions to ask: 
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i. Who can 
participate? 
• How does our project actively address disparities in position, access, 
experience or resources?  
• What explicit codes of conduct do participants agree upon, and how are they 
determined?  
• Do our website descriptions include visual aids and multimedia pieces? 
ii. What are the 
barriers? 
• What fees or conditions (tools, skills, software, time, training) are necessary 
for participation?  
• How do these conditions shape the resulting data set?  
• Do website descriptions include visual aids and multimedia pieces that 
explain in plain language the aims of the project, and how to participate? 
• What forms of literacy (scientific, medical, digital, English language) are 
required? 
iii. What are the 
burdens of 
engagement? 
• What responsibilities or burdens are borne by participants? 
• Were any of the services offered by the initiative previously provided by 
other groups, organizations, or states? If so, are they still available?  
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iv. Who should 
benefit, and how? 
• Who is the intended public, how can they benefit?  
• Who is empowered or disempowered in the process, and how?   
• What specific, local benefits (as opposed to broad, global claims) are 
provided? 
v. How are results 
distributed 
• How can we make our products of better service to (wider ranges of) the 
public?  
• Are results and tools open access and publically available?  
• Are the products or end results, whenever possible, made from affordable, 
easy to use materials? Are the necessary instructions also shared to facilitate 
use? 
R
ep
re
se
n
ta
ti
o
n
 a
n
d
 R
ec
o
g
n
it
io
n
 
 
vi. What data are 
available to 
participants and 
publics? 
• What are the enabling or limiting conditions of data access and use?  
• Are data contextualized, and what further provisions are necessary for data to 
be intelligible or useful?  
• Are participants compensated for their labor or donations? 
• Is data access feasible for marginalized groups or for those living in resource-
poor areas? What benefits (as well as costs and risks) does data access entail 
for them? 
vii. Who do the 
data represent? 
• Are members of marginalized groups involved in developing research aims 
and recruitment strategies? 
• If working with members of indigenous groups, are participants co-
collaborators on the project? Do they retain determination over final use of 
results, data, or products? 
• What markers of difference are used? How are they determined?  
• How often are questions of representation revisited during our project? 
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viii. Recognize 
historic 
injustices, avoid 
repeating 
• Do relevant histories of gender-related, racial and colonial violence inform 
our project, and if so, which ones? 
• Does our initiative publically recognize how it may benefit from, replicate, or 
operate within institutions of structural violence and exclusion, and take steps 
to avoid repeating this in the future? 
ix. Think about 
trust and be 
trustworthy 
• Who is likely to “opt-in” to the project, and who is not? What role does trust 
play in this process? 
• Are there pertinent histories of marginalization that might influence the 
groups choosing to participate and who do not? 
• What can we do to increase the trustworthiness of our initiative in meaningful 
ways? 
 
x. Consider 
global justice 
• Could the collection of samples, reporting of real-time events, or posting of 
personal data online pose personal harms to individuals, particularly those in 
poorer regions of the world?  
• Are there any possible harms that could materialize along the global 
socioeconomic gradient, of particular relevance for marginalized, resource-
poor populations? 
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Conclusion 
 The incorporation of citizen science into new areas of health research potentially 
promises significant health and societal benefits.[56, 57] However, it also engenders concerns 
that have not been fully addressed by scholars, practitioners, and funders working in the areas 
of health and medical research. We have argued that greater attention needs to be paid to the 
discursive and material exclusions that occur for underserved populations in participatory 
forms of health research. Given that many initiatives make an explicit claim to inclusion, it 
would be reasonable to expect meaningful participation in such initiatives, and that resulting 
benefits are equitable. This means that benefits need to be both accessible and actionable by 
participants – in particular those who are resource-poor, located outside of service networks, 
non-white/western, or have been historically marginalized by biomedicine.  
 This does not mean advocating a tokenistic approach to inclusion that can essentialize 
notions of race or gender, and overlook how data collection is entangled with histories of 
colonization and exclusion. Instead, and in additional to existing guidance on ethical research 
practices in health and medicine,[9–11] we argue for the creation of specific, proactive steps 
for the inclusion of various peoples and publics, which will vary with the goals, needs, 
settings, and historical precedents of individual projects. As a first step, we have compiled 
questions that those designing, running, funding, participating in, or providing ethical 
oversight for citizen science projects could consider in Table 1. These recommendations are 
intended contextually; each project should engage with the concerns most relevant to 
collaborators. 
 Many citizen science projects have been made possible by advances in tools and 
strategies to collect, store and analyze digital data that are transforming global and public 
health. Hailed for their affordability, real-time data, and greater reach, such technologies also 
imply ethical obligations, especially when they involve the collection of samples and data 
from underserved populations. If citizen science initiatives are to fulfill their potential of 
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serving the public good, they should address a diverse set of needs, and do so in a way such 
that the collection and analysis of data is informed by the interests of those involved. We 
advocate that these concerns be built into the very design of citizen science and participatory 
health projects, rather than treated as retrospective constraints. Given the attention participant-
centric initiatives often command, there is great potential to engage in public reflection on 
questions of cultural relativity, standards of privacy, data ownership, and accountability that 
are persistent concerns in medicine, bioethics, and public health. 
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